SNAP-7941
 | |
| Identifikatori | |
|---|---|
| ATC kod | none |
| ChEMBL | CHEMBL185271 |
| Hemijski podaci | |
| Formula | C33H41F2N5O6 |
| Molarna masa | 641,704 |
| |
SNAP-7941 je lek koji se koristi u naučnim istraživanjima. On je selektivni nepeptidni antagonist melanin-koncentrirajućeg hormonskog receptora MCH1. U životinjskim studijama je pokazano da proizvodi anksiolitičke, antidepresivne i anoreksne efekte.[1][2] Međutim, rezultati kliničkih ispitivanja su bili razoračaravajući.[3] SNAP-7941 je značajan kao vodeće jedinjenje iz kojeg su potentniji i selektivniji antagonist i razvijeni, poput SNAP-94847,[4][5] mada se ovo jedinjenje i dalje koristi u istraživanjima funkcija MCH1 receptora.[6][7]
Reference[уреди | уреди извор]
- ^ Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, Lagu B, Heurich R, Lichtblau H, Shaposhnik Z, Daniewska I, Blackburn TP, Branchek TA, Gerald C, Vaysse PJ, Forray C (2002). „Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist”. Nature Medicine. 8 (8): 825—30. PMID 12118247. doi:10.1038/nm741.
- ^ Doggrell SA (2003). „Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?”. Expert Opinion on Investigational Drugs. 12 (6): 1035—8. PMID 12783607. doi:10.1517/13543784.12.6.1035.
- ^ Basso AM, Bratcher NA, Gallagher KB, Cowart MD, Zhao C, Sun M, Esbenshade TA, Brune ME, Fox GB, Schmidt M, Collins CA, Souers AJ, Iyengar R, Vasudevan A, Kym PR, Hancock AA, Rueter LE (2006). „Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety”. European Journal of Pharmacology. 540 (1-3): 115—20. PMID 16765941. doi:10.1016/j.ejphar.2006.04.043.
- ^ Jiang Y, Chen CA, Lu K, Daniewska I, De Leon J, Kong R, Forray C, Li B, Hegde LG, Wolinsky TD, Craig DA, Wetzel JM, Andersen K, Marzabadi MR (2007). „Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists Part 1. The discovery of arylacetamides as viable replacements for the dihydropyrimidinone moiety of an HTS hit”. Journal of Medicinal Chemistry. 50 (16): 3870—82. PMID 17668921. doi:10.1021/jm060381c.
- ^ Chen CA, Jiang Y, Lu K, Daniewska I, Mazza CG, Negron L, Forray C, Parola T, Li B, Hegde LG, Wolinsky TD, Craig DA, Kong R, Wetzel JM, Andersen K, Marzabadi MR (2007). „Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits”. Journal of Medicinal Chemistry. 50 (16): 3883—90. PMID 17668922. doi:10.1021/jm060383x.
- ^ Millan MJ, Gobert A, Panayi F, Rivet JM, Dekeyne A, Brocco M, Ortuno JC, Di Cara B (2008). „The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 11 (8): 1105—22. PMID 18466669. doi:10.1017/S1461145708008894.
- ^ Hegde LG, Ping XL, Jochnowitz N, Craig DA (2009). „The role of melanin-concentrating hormone-1 receptors in the voiding reflex in rats”. The Journal of Pharmacology and Experimental Therapeutics. 328 (1): 165—73. PMID 18849359. doi:10.1124/jpet.108.143495.
Spoljašnje veze[уреди | уреди извор]
 | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
